What is the impact of type 2 diabetes mellitus on CYP450 metabolic activities? DOI Open Access
Brian Tomlinson, Yanhong Li

Expert Opinion on Drug Metabolism & Toxicology, Journal Year: 2023, Volume and Issue: 19(12), P. 867 - 870

Published: Nov. 24, 2023

KEYWORDS: cytochrome P450 (CYP)CYP2C19nonalcoholic fatty liver diseasenonalcoholic steatohepatitisobesitytype 2 diabetes

Language: Английский

Liver-specific actions of GH and IGF1 that protect against MASLD DOI
Rhonda D. Kineman,

Mercedes Del Rio-Moreno,

David J. Waxman

et al.

Nature Reviews Endocrinology, Journal Year: 2024, Volume and Issue: unknown

Published: Sept. 25, 2024

Language: Английский

Citations

2

Pharmacogene expression during progression of metabolic dysfunction-associated steatotic liver disease: Studies on mRNA and protein levels and their relevance to drug treatment DOI Creative Commons
Olivier Govaere, Simon Cockell,

Michalina Zatorska

et al.

Biochemical Pharmacology, Journal Year: 2024, Volume and Issue: 228, P. 116249 - 116249

Published: April 30, 2024

Metabolic dysfunction-associated steatotic liver disease (MASLD) is common worldwide. Genes and proteins contributing to drug disposition may show altered expression as MASLD progresses. To assess this further, we undertook transcriptomic proteomic analysis of 137 pharmacogenes in biopsies from a large cohort. We performed sequencing on RNA 216 (206 10 controls). Untargeted mass spectrometry proteomics was 103 biopsy subgroup. Selected signals were replicated with an additional 187 biopsies. Comparison advanced (fibrosis score 3/4) milder 0-2) by showed significant alterations certain phase I, II ABC transporters. For cytochromes P450, CYP2C19 the most decreased (30 % that mild disease) but other CYPs (including CYP2C8 CYP2E1) also occurred. decrease comparing inflammatory form (MASH) non-MASH Findings for confirmed replication Proteomics original discovery cohort levels several greatest where fell 40 control. This result activity could be problematic prescription drugs activated or metabolized advances. More limited decreases P450s suggest fewer issues non-CYP2C19 substrates. Negative correlations at level between cytokine genes provided initial insights into mechanism underlying expression.

Language: Английский

Citations

1

Multiscale 3D genome organization underlies duck fatty liver with no adipose inflammation or serious injury DOI Creative Commons

Mengfei Ning,

Linfei Song,

Xinyu Niu

et al.

International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 271, P. 132452 - 132452

Published: May 20, 2024

Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic disease. Little known about how gene expression and chromatin structure are regulated in NAFLD due to lack suitable model. Ducks naturally develop similar serious human non-alcoholic (NAFL) without adipose inflammation fibrosis, thus serves as a good model for investigating molecular mechanisms metabolism anti-inflammation. Here, we constructed fibrosis ducks. By performing dynamic pathological transcriptomic analyses, identified critical genes involving regulation NF-κB MHCII signaling, which usually lead fibrosis. We further generated three-dimensional maps during formation recovery. This showed that ducks enlarged hepatocyte cell nuclei reduce inter-chromosomal interaction, decompress structure, alter strength intra-TAD loop interactions formation. These changes partially contributed tight control signaling. Our analysis uncovers duck reorganization might be advantageous maintain regenerative capacity inflammation. findings shed light on new strategies control.

Language: Английский

Citations

1

Gut microbiota trigger host liver immune responses that affect drug-metabolising enzymes DOI Creative Commons

Jiaoyu Rao,

Peng Qiu, Yonggang Zhang

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: Dec. 11, 2024

There is increasing evidence that the intestinal microbiota plays an integral role in disease pathogenesis and treatment. Specifically, significantly influences pharmacokinetics pharmacodynamics of orally administered drugs through direct involvement drug metabolism and, consequently, bioavailability. However, gut also exerts immunoregulatory effects on liver-the organ primarily responsible for metabolism-thereby indirectly impacting body's capacity to metabolise process drugs. Individual differences this pathway substantially contribute variability clinical treatment outcomes observed between patients. This review examines impact liver immune responses, as triggered by microbiota, activity drug-metabolising enzymes discusses implications precision medicine.

Language: Английский

Citations

1

Virgin flaxseed oil supplemented or not with tocopherols and phytosterols prevents liver steatosis induced by high‐fat diets in male Wistar rats DOI
Ignacio Gabriel Scanarotti, Juliana Saín,

Ana Patricia Fabro

et al.

European Journal of Lipid Science and Technology, Journal Year: 2024, Volume and Issue: 126(5)

Published: March 13, 2024

Abstract This study aimed to investigate the effect of a virgin flaxseed oil (FO) rich in n − 3 polyunsaturated fatty acid, supplemented or not with bioactive supplement (BS) containing tocopherols and phytosterols on prevention nonalcoholic liver disease high‐fat (HF) animal model. Male Wistar rats were fed 60 days recommended (SO7, soybean 7%) an HF diet (fat, 30%) (SO30), corn (CO30), FO (FO30) same oils 1% BS (SO30BS, CO30BS, FO30BS, respectively). Hepatic dietary FA composition, triacylglycerides (TAGs) content serum liver, nutritional parameters, vivo TAG‐secretion rate, histology, mRNA levels β‐oxidation‐related genes, carnitine palmitoyl transferase‐1a (CPT‐1a) enzyme activity determined. At levels, FO30 FO30BS groups showed highest total PUFA diets associated lower weight gain, TAG content, microsteatosis degree. The CPT‐1a was enhanced showing differences only by type oil. supplementation induced increase gene expression. Virgin prevented steatosis hepatomegaly diets. reduced body fat accumulation expression β‐oxidation related without affecting hepatic content. Practical Applications : Scientific knowledge functional lipids high oxidative stability biological has great practical application reducing non‐communicable chronic diseases. provides evidence potential synergic complementary effects FO, TP, PS be used for metabolic disorders involved during evolution different steps NAFLD. Specifically, based mechanisms, this stable combination could prevent development exacerbated but also hepatocellular injury seen at stages from steatohepatitis.

Language: Английский

Citations

0

Disrupted Host-Microbiota Crosstalk Promotes Nonalcoholic Fatty Liver Disease Progression by Impaired Mitophagy DOI Creative Commons
Wenjing Yin, Wenxing Gao,

Yuwei Yang

et al.

Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown

Published: June 14, 2024

Abstract Background: The intricate interplay between host genes and intrahepatic microbes is vital in shaping the hepatic microenvironment contributes significantly to our understanding of nonalcoholic fatty liver disease (NAFLD). However, underlying mechanisms progression mediated by these interactions remain largely elusive. Methods: We conducted a comprehensive analysis 570 biopsy transcriptomes from five cohorts, including 72 control, 124 (NAFL), 143 borderline 231 steatohepatitis (NASH) samples. Least Absolute Shrinkage Selection Operator penalized regression Sparse Canonical Correlation Analysis were utilized identify host-microbiota their function. Results: observed significant upregulations key involved mitochondrial organization across all stages, while related antigen processing showed abnormal activations advanced stages like NASH. Additionally, abundances Methyloversatilis sp. RAC08 Ralstonia insidiosadecreased NAFLD stages. identified 5537, 1937, 1485, 2933 NAFL, borderline, NASH samples, respectively. Notably, interaction strength decreasing trend, especially during transition stage In NAFL bacteria Bacillales, insidiosa, Micromonosporaceae played pivotal roles enhancing mitophagy interacting with SQSTM1, OPTN, BNIP3L. such functional clusters absent Conclusion: Disturbed affecting process can lead pro-inflammatory through activation immune reactions, potentially driving

Language: Английский

Citations

0

Development of a novel diagnostic model to monitor the progression of metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma in females DOI Creative Commons

Xiaoning Gan,

Yun Zhou, Y F Li

et al.

Discover Oncology, Journal Year: 2024, Volume and Issue: 15(1)

Published: Dec. 19, 2024

The onset of metabolic dysfunction-associated steatotic liver disease-associated hepatocellular carcinoma (MASLD-HCC) is insidious and exhibits sex-specific variations. Effective methods for monitoring MASLD-HCC progression in females have not yet been developed. Transcriptomic data female tissue samples were obtained from multiple public databases. Differentially expressed genes (DEGs) identified using differential expression robust rank aggregation analyses. Diagnostic prediction models MASLD (DP.MASLD) HCC (DP.HCC) developed validated elastic net analysis, diagnostic performance was evaluated receiver operating characteristic (ROC) curve analysis. Bioinformatics used to assess the pathogenesis MASLD-HCC. Seven overlapping DEGs patients with HCC: AKR1B10, CLEC1B, CYP2C19, FREM2, MT1H, NRG1, THBS1). area under ROC (AUC) values training validation groups DP.MASLD model 0.864 0.782, 0.932 1.000, 0.920 0.969 when differentiating between steatosis normal liver, steatohepatitis steatosis, groups, respectively. AUCs DP.HCC 0.980 0.997 oncogenesis associated molecular pathways, including cytochrome P450-associated drug metabolism, tyrosine fatty acid degradation, focal adhesion, extracellular matrix receptor interactions, protein digestion absorption. A novel effective method quantitatively risk developed, this will aid generation precise diagnostic, preventive, therapeutic strategies.

Language: Английский

Citations

0

Steatotic liver disease in metastatic breast cancer treated with endocrine therapy and CDK4/6 inhibitor DOI
Diego Malón,

Consolación Molto,

Shopnil Prasla

et al.

Breast Cancer Research and Treatment, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 25, 2024

Language: Английский

Citations

0

Alleviating batch effects in cell type deconvolution with SCCAF-D DOI Creative Commons
Shuo Feng, Liangfeng Huang, Anna Vathrakokoili Pournara

et al.

Nature Communications, Journal Year: 2024, Volume and Issue: 15(1)

Published: Dec. 30, 2024

Cell type deconvolution methods can impute cell proportions from bulk transcriptomics data, revealing changes in disease progression or organ development. But benchmarking studies often use simulated data the same source as reference, which limits its application scenarios. This study examines batch effects and introduces SCCAF-D, a computational workflow that ensures Pearson Correlation Coefficient above 0.75 across real for various tissue types. Applied to non-alcoholic fatty liver disease, SCCAF-D unveils meaningful insights into during progression.

Language: Английский

Citations

0

Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities DOI Open Access
Joost Boeckmans, Alexandra Gatzios, Jörn M. Schattenberg

et al.

Archives of Toxicology, Journal Year: 2023, Volume and Issue: 97(6), P. 1825 - 1827

Published: May 6, 2023

Language: Английский

Citations

1